Isofol Medical AB (publ)

DB:5IU Stock Report

Market Cap: €33.8m

Isofol Medical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:5IU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
21 Aug 24Buy€1,845Petter LindqvistIndividual7,777€0.24
12 Jul 24Buy€1,669Petter LindqvistIndividual7,777€0.21
05 Jul 24Buy€642Petter LindqvistIndividual7,777€0.083

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 5IU?
Owner TypeNumber of SharesOwnership Percentage
Institutions26,172,28016.2%
Individual Insiders35,593,41422%
General Public99,749,74661.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 18 shareholders own 38.79% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.86%
Avanza Fonder AB
15,932,995€3.3m0%0.05%
4.73%
Christian Haglund
7,636,506€1.6m0%no data
3.95%
Swedbank Försäkring AB, Asset Management Arm
6,372,690€1.3m0%3.56%
3.69%
Mats Franzén
5,952,393€1.2m0%no data
3.52%
Göran Gustafsson
5,689,367€1.2m0%no data
2.82%
Hans Enocson
4,555,236€952.2k0%no data
2.38%
Claes Ekman
3,850,000€804.8k0%no data
2.32%
Bengt Gustavsson
3,749,459€783.8k0%no data
1.89%
Hans Wiklund
3,044,659€636.4k0%no data
1.38%
Futur Pension Försäkringsaktiebolag, Asset Management Arm
2,228,252€465.8k0%0.16%
0.63%
SEB Investment Management AB
1,019,786€213.2k0%no data
0.56%
Handelsbanken Asset Management
900,000€188.1k0%no data
0.4%
Jan-Eric Österlund
640,000€133.8k0%no data
0.28%
FCG Fonder AB
447,470€93.5k0%0.01%
0.25%
Lars Lind
407,362€85.2k0%no data
0.099%
Skandia Fonder AB
159,422€33.3k0%no data
0.04%
Petter Lindqvist
65,331€13.7k55.6%no data
0.0019%
Sten Nilsson
3,101€648.20%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:49
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Isofol Medical AB (publ) is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ulrik TrattnerCarnegie Investment Bank AB
Ole-Andreas KrohnDNB Markets
David MartinssonDNB Markets